Jeremy Kobulnik

Medical director, Heart Transplantation, CareDx

[Jeff Teuteberg @JeffTeuteberg]

🗣️Early trajectories of cell free 🧬 correlated with outcomes!
Data from @CareDx’s KAOR registry presented this am @AST_info #ATC2026

More evidence for insights from longitudinal data with protocol-based testing!

Stay tuned 🎙️ for more evidence from the KAOR investigators.

[Jeff Teuteberg @JeffTeuteberg]

🔥 off the presses @JASN_News from @CareDx's KOAR registry‼️
Transition to elevated cfDNA associated with:
➡️Adjusted HR of allograft dysfunction:
Intermediate: 3.7X ⬆️
High: 6.4X ⬆️
➡️Even 1⃣ elevation in AlloSure associated with worse clinical trajectory.

[Jeff Teuteberg @JeffTeuteberg]

Good morning and Happy Father’s Day! Early start at @AST_info #ATC2026 with PI meeting for @CareDx’s KOAR and OKRA studies in kidney transplant. New insights on the use of cfDNA are on the way!
@amjtransplant @ASTSChimera

[Jeff Teuteberg @JeffTeuteberg]

⏲️ it’s on! @CareDx’s lunchtime symposium @AST_info #ATC2026: Molecular insights to confident clinical decision making!

An interactive case-based discussion by our panel of experts!
@jfriedo @DeirdreSawinski @UTSWMedCenter @NyuMed @NorthwesternMed

[Jeff Teuteberg @JeffTeuteberg]

The wait is finally over — it is time for #ATC2026!
I’m excited to be in Boston with @CareDx to connect with others in the transplant community.
If you’re attending, make sure to stop by Booth #401.
@AST_info @amjtransplant

[Jeff Teuteberg @JeffTeuteberg]

@AST_info's #ATC2026 is right around the corner!
I’m excited to join my @CareDx colleagues in the transplant community in Boston!
If you’re there, let’s connect.
#TogetherInTransplant #TransplantInnovation #TransplantCare
#OrganTransplant #Transplant #CareDx

[Jeff Teuteberg @JeffTeuteberg]

Strategy session with @CareDx Medical Affairs Leadership today in @CityOfDallas. Looking forward to trials, publications, collaborations and education with our colleagues in 🫀🫁🫘 & liver #transplant in 2027 and beyond‼️ @ISHLT @tcccop @AST_info @TheJHLT @amjtransplant

[CareDx® @CareDx]

A new article in @CardioBusiness, featuring insights from @JeffTeuteberg and @JKobulnik , explores how our HeartCare platform—combining AlloMap® and AlloSure® Heart—is changing the post-transplant care path for #hearttransplant recipients.

[Jeff Teuteberg @JeffTeuteberg]

🎉Congratulations to Robert Woodward on his 25th anniversary @CareDx‼️
His leadership has helped guide the development and evolution of innovations across our history and he embodies our mission and dedication to patients.

[Jeff Teuteberg @JeffTeuteberg]

The wait is over — #ISHLT2026 is here!
I’m excited to be in Toronto with @CareDx to connect with the transplant community.
If you’re attending, make sure to stop by booth 505.
#TogetherInTransplant #TransplantInnovation #TransplantCare #OrganTransplant
#Transplant #CareDx

[Amin Yehya, MD, MS, FACC, FHFSA @AminYehyaMD]

We are getting closer and closer to biopsy free future. Check out latest work in JACC-HF on how #ddcfDNA identifies #AMR, severity, and possible response to therapy. #hearttransplant #rejection #biopsy

[Nir Uriel, MD MSc @NirUrielMD]

Our latest analysis from the SHORE registry now in @TheJHLT comprised of nearly 2000 pts with heart transplant

Read here about the risk of dual + GEP/dd-cfDNA

https://t.co/p1sXtXIPBw

@JeffTeuteberg @KiranKhush1 @CareDx

[JHLT @TheJHLT]

SHORE registry: Dual molecular testing improved performance for ACR surveillance vs single molecular testing (lower biopsy rates, excellent survival, low incidence of graft dysfunction) @KiranKhush1 @shelleyhallmd @PalakShahMD @NirUrielMD @spinneymd @davebaran @JeffTeuteberg

🔗: https://t.co/OXCaEaopPx

[Yas Moayedi @YasMoayedi]

Thrilled to share: https://t.co/Dq0MhNnZAt where we propose a new paradigm, moving away from biopsies as the gold standard. Huge thanks to @JeffTeuteberg for his mentorship and unwavering support! #patientcentredcare #HeartTransplant #Innovation @Womenintxp_mcs

[Keegan Matheson @KeeganMatheson]

Trade: The #BlueJays announce they’ve acquired RHP Yerry Rodríguez from the Texas Rangers in exchange for RHP Josh Mollerus.

Rodríguez will head to Triple-A.

[Yas Moayedi @YasMoayedi]

Huge congrats on redefining rejection and changing the status quo @JKobulnik @JeffTeuteberg @KiranKhush1

[Kiran Khush @KiranKhush1]

Brainstorming innovative ways to improve the care and outcomes of #hearttransplant patients at ⁦@CareDx⁩ advisory board meeting in beautiful Chicago-new ideas for AI and molecular diagnostics. ⁦@NirUrielMD⁩ ⁦@JeffTeuteberg⁩ ⁦@HannahValantine⁩

[CareDx® @CareDx]

Taking place this morning! Join CareDx at #ISHLT2023 from 11:30 a.m.-12:30 p.m. for its Heart Symposium featuring this incredible line-up of speakers. For more details, visit https://t.co/KTzITX9abs
#ISHLT2023

[PGA TOUR @PGATOUR]

Add that check ✅❤️